These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2713701)

  • 1. Involvement of nigrotecto-reticulospinal pathways in the iminodipropionitrile (IDPN) model of spasmodic dyskinesias: a 2-deoxy-D-[1-14C]glucose study in the rat.
    Cadet JL; Della Puppa A; London E
    Brain Res; 1989 Apr; 484(1-2):57-64. PubMed ID: 2713701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional changes in brain 5-HT1A serotonin receptors in the rat model of persistent spasmodic dyskinesias induced by iminodipropionitrile.
    Przedborski S; Wright M; Fahn S; Cadet JL
    Brain Res; 1989 Dec; 504(2):311-4. PubMed ID: 2532054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative autoradiographic changes in 5-[3H]HT-labeled 5-HT1 serotonin receptors in discrete regions of brain in the rat model of persistent dyskinesias induced by iminodipropionitrile (IDPN).
    Przedborski S; Wright M; Fahn S; Cadet JL
    Neurosci Lett; 1990 Aug; 116(1-2):51-7. PubMed ID: 2259456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The iminodipropionitrile (IDPN) model of persistent spasmodic dyskinesias: regional serotonin metabolism in rat brain.
    Cadet JL; Jackson-Lewis V; Fahn S
    Brain Res; 1988 Jul; 456(2):371-4. PubMed ID: 2463039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential changes in 125I-LSD-labeled 5-HT-2 serotonin receptors in discrete regions of brain in the rat model of persistent dyskinesias induced by iminodipropionitrile (IDPN): evidence from autoradiographic studies.
    Cadet JL; Kuyatt B; Fahn S; De Souza EB
    Brain Res; 1987 Dec; 437(2):383-6. PubMed ID: 3435844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoradiographic evidence of [3H]neurotensin binding changes in discrete regions of brain in the rat model of persistent spasmodic dyskinesia induced by iminodipropionitrile.
    Przedborski S; Wright M; Fahn S; Cadet JL
    Neurosci Lett; 1989 Dec; 107(1-3):335-40. PubMed ID: 2616045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional (14C) 2-deoxyglucose uptake during vibrissae movements evoked by rat motor cortex stimulation.
    Sharp FR; Evans K
    J Comp Neurol; 1982 Jul; 208(3):255-87. PubMed ID: 7119161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the putative GABAergic agonists, muscimol and THIP, upon local cerebral glucose utilisation.
    Kelly PA; McCulloch J
    J Neurochem; 1982 Sep; 39(3):613-24. PubMed ID: 7097270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the GABA receptor agonist, progabide, upon local cerebral glucose utilization.
    Cudennec A; Duverger D; Lloyd KG; MacKenzie ET; McCulloch J; Motohashi N; Nishikawa T; Scatton B
    Brain Res; 1987 Oct; 423(1-2):162-72. PubMed ID: 2823984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection by 2-deoxy-D-glucose against beta,beta'-iminodipropionitrile-induced neurobehavioral toxicity in mice.
    Tariq M; Khan HA; al Moutaery K; al Deeb S
    Exp Neurol; 1999 Jul; 158(1):229-33. PubMed ID: 10448436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local cerebral glucose utilization in the AS/AGU rat: a mutant with movement disorders.
    Lam AG; Campbell JM; Bennett NK; Payne AP; Davies RW; Sutcliffe RG; McCulloch J
    Eur J Neurosci; 1998 Jun; 10(6):1963-7. PubMed ID: 9753083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic response to optic centers to visual stimuli in the albino rat: anatomical and physiological considerations.
    Toga AW; Collins RC
    J Comp Neurol; 1981 Jul; 199(4):443-64. PubMed ID: 6168665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protein synthesis inhibitor, anisomycin, causes exacerbation of the iminodipropionitrile-induced spasmodic dyskinetic syndrome in rats.
    Stennett R; Katz M; Jackson-Lewis V; Fahn S; Cadet JL
    Pharmacol Biochem Behav; 1989 Apr; 32(4):1003-8. PubMed ID: 2477862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonidine and prazosin block the iminodipropionitrile (IDPN)-induced spasmodic dyskinetic syndrome in mice.
    Cadet JL; Braun T; Freed WJ
    Pharmacol Biochem Behav; 1987 Apr; 26(4):791-5. PubMed ID: 3037570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurovestibular toxicities of acrylonitrile and iminodipropionitrile in rats: a comparative evaluation of putative mechanisms and target sites.
    Khan HA; Alhomida AS; Arif IA
    Toxicol Sci; 2009 May; 109(1):124-31. PubMed ID: 19244277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The iminodipropionitrile (IDPN)-induced dyskinetic syndrome in mice: antagonism by the calcium channel antagonist nifedipine.
    Cadet JL; Taylor E; Freed WJ
    Pharmacol Biochem Behav; 1988 Feb; 29(2):381-5. PubMed ID: 2452450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of thyrotropin-releasing hormone (TRH) on local cerebral glucose utilization, by the autoradiographic 2-deoxy[14C]glucose method, in conscious and pentobarbitalized rats.
    Nagai Y; Narumi S; Nagawa Y; Sakurada O; Ueno H; Ishii S
    J Neurochem; 1980 Oct; 35(4):963-71. PubMed ID: 6778968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 1,3-di-o-tolylguanidine (DTG), a sigma ligand, on local cerebral glucose utilization in rat brain.
    Hohmann AG; Matsumoto RR; Hemstreet MK; Patrick SL; Margulies JE; Hammer RP; Walker JM
    Brain Res; 1992 Oct; 593(2):265-73. PubMed ID: 1450934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine enhances cerebral glucose utilization in central components of the rat visual system.
    London ED; Dam M; Fanelli RJ
    Brain Res Bull; 1988 Mar; 20(3):381-5. PubMed ID: 3365564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exacerbation of iminodipropionitrile-induced behavioral toxicity, oxidative stress, and vestibular hair cell degeneration by gentamicin in rats.
    Al Deeb S; Al Moutaery K; Khan HA; Tariq M
    Neurotoxicol Teratol; 2000; 22(2):213-20. PubMed ID: 10758350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.